A Study to Evaluate the Efficacy and Safety of Bismuth-Containing Quadruple Therapy With Oral Vonoprazan (TAK-438) 20 mg Compared to Esomeprazole 20 mg Twice Daily in Paticipants With Helicobacter Pylori Infection
Condition: Helicobacter Pylori Interventions: Drug: Vonoprazan; Drug: Amoxicillin; Drug: Clarithromycin; Drug: Bismuth Potassium citrate; Drug: Esomeprazole Sponsor: Takeda Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Amoxicillin | Biaxin | Clarithromycin | Esomeprazole | Helicobacter Pylori | Nexium | Research | Study